Merck Serono of Geneva, Switzerland plans to invest more than €150 million in a new centre for pharmaceutical research and development in Beijing, China. The new centre will be in addition to R&D centres in Germany, Switzerland and the US. ---Subscribe to MedNous to access this article--- Company News
